Pharm Flashcards

(42 cards)

1
Q

Cox 1 actions

A
renal function
bronchodilation/constriction
acute prostaglandin production
gastric cytoprotection
platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cox 2 actions

A

renal function
bronchodilation/constriction
sustained prostaglandin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COX1 and COX2 shared functions

A

renal function

bronchodilation/constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COX1 only functions

A

gastric cytoprotection

platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PGE1

A

vasodilation

maintenance of patent ductus arteriosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PGE2

A
vasodilation
diuresis- Na and K loss in urine
patent ductus arteriosus
gastric cytoprotection
pain sensitization
fever
uterine and GI smooth muscle contraction
relaxation of respiratory smooth muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PGF2

A

vasoconstriction
increased aqueous humor drainage
uterine, GI, and respiratory smooth muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

changes in vessel diameter

A

vasodilation- PGE1, PGE2, PGI2

vasoconstriction- PGF2, TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

uterine changes

A

contraction- PGE2, PGF2

relaxation- PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GI contraction

A

PGE2

PGF2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

respiratory changes

A

contraction- PGF2, TXA2, leukotrienes C, D, E

relaxation- PGE2, PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PGI2

A

vasodilation- diuresis, NA and K loss in urine
gastric cytoprotection
pain sensitization
fever
relaxation of uterine and respiratory smooth muscle
prevents spontaneous platelet aggregation- inhibits TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

gastric cytoprotection

A

PGE2

PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pain sensitization

A

PGE2
PGI2
leukotrienes (LTB4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

fever

A

PGE2

PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TXA2

A

vasoconstriction
contraction of respiratory smooth muscle
platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

platelet aggregation

A

inhibit- PGI2

promote- TXA2

18
Q

LTC4, LTD4, LTE4

A

bronchoconstriction

increased vascular permeability

19
Q

LTB4

A

chemoattraction

pain sensitization

20
Q

EP1

21
Q

EP2

A

vascular smooth muscle relaxation

22
Q

EP3

A
vascular smooth muscle relaxation
decreased gastric acid secretion
increased gastric mucus secretion
uterine contraction
fever
23
Q

EP4

A

vascular smooth muscle relaxation

pain sensitization

24
Q

budesonide

A

short half life
used in asthma inhalers
easily penetrates airway mucosa

25
dexamethasone
very potent long half life oral, parenteral, topical multipurpose
26
fluticasone
asthma inhalers and nasal sprays medium potency short half life
27
hydrocortisone (cortisol)
low potency OTC for skin also used PO and parenteral used for adrenal insufficiency replacement medium half life
28
mometasone
medium potency asthma and skin not metabolized in skin, so can cause local side effects systemically absorbed *not as commonly used as budesonide or fluticasone
29
prednisone
long half life prodrug metabolized by liver PO only used for inflammatory conditions
30
prednisolone/methylprednisolone
active metabolite of prednisone used in hepatic disease patients PO, inject, eye drops no bioactivation required
31
triamcinolone
oral, injection, topical potency depends on formulation causes skin issues like mometasone
32
ibuprofen
COX1 pain, fever, OA, RA, dysmenorrhea topical for MSK and dental pediatric- fever
33
naproxen
COX1 similar to ibuprofen LONG half life used 2x daily for arthritis
34
piroxicam
COX1 OA, RA long half life- once daily noncox mediated anti-inflammatory effects high doses more likely to cause peptic ulcers than other NSAIDs
35
indomathacin
COX1 extensive toxicities with severe sideffects used to reverse acute disorders- pericarditis, patent ductus closure, acute gout attack few, night time doses
36
sulindac
``` COX1 RA, OA, gout polyp regression in familial adenomatous polyposis prodrug less GI irritation high CNS effects enterohepatic recycling ```
37
ketoralac
``` COX1 analgesic- better than morphine used with opioids and reduces required opioid dose not anti-inflammatory high risk renal toxicity do not use more than 5 days renal impairment- contraindication ```
38
nabumetone
``` COX1 and COX2 OA, RA, pain non acid NSAID metabolized to weak acid to be activated >24 hour half life pseudoporphyria and photoinsensitivity ```
39
etodolac
COX2 OA, RA less GI ulceration
40
diclofenac
OA, RA less likely to cause GI ulcerations topical gel for localized arthritis more likely to elevate liver enzymes
41
celecoxib
cox 2 selective OA, RA promote regression of polyps lower GI ulceration, but can delay healing of existing ulcers increased risk of Cardiovascular adverse efects
42
meloxicam
cox 2 selective OA, RA low doses have fewer GI sed effects activity is dose dependent